PATEL SAMIR CHANDRAKANT
SEC CIK 1277966 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | Dir | 100.8K | — | — | 2 | 2025-03-18 | 2025-03-18 |
Most active insiders at KLRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| 2 | AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| 3 | Hagen Brett R | CAO | — | $12.9K |
PATEL SAMIR CHANDRAKANT made no open-market trades at KLRS in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-03-18 | 2025-03-18 | KLRS | Kalaris Therapeutics, Inc. | PATEL SAMIR CHANDRAKANT | Dir | A - Grant | — | +100.8K | 100.8K | New | — |
| D | 2025-03-18 | 2025-03-18 | KLRS | Kalaris Therapeutics, Inc. | PATEL SAMIR CHANDRAKANT | Dir | A - Grant | — | +252.0K | 252.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations